Citations

Showing 10 of 108081 citations.

Medical Education at Mayo Clinic (Mayo Medical School)
Daube, Jasper R.

Mayo Clinic

Journal of UOEH | April 10, 2017 | Volume: 13 | Issue: 3 | Pages: 207-215

10.7888/juoeh.13.207 | PMID 1925144 Get It

Neuroembryology of the Acupuncture Principal Meridians: Part 2. The Trunk
Dorsher, Peter T.

Mayo Clinic

Medical Acupuncture | April 10, 2017 | Volume: 29 | Issue: 2 | Pages: 77-86

10.1089/acu.2016.1211 Get It

ThT 101: a primer on the use of thioflavin T to investigate amyloid formation
Malmos, Kirsten Gade , Blancas‐Mejía, Luis M. , Weber, Benedikt , Büchner, Johannes , Ramı́rez-Alvarado, Marina , Naiki, Hironobu , Otzen, Daniel E. , Otzen, Daniel , Ramirez-Alvarado, Marina

Mayo Clinic

Amyloid | April 10, 2017 | Volume: 24 | Issue: 1 | Pages: 1-16

10.1080/13506129.2017.1304905 | PMID 28393556 Get It

Successful use of family‐based therapy interventions for uncontrolled type 1 diabetes in an adolescent
Wilfahrt, Robert P. , Matthews, Abigail , Lenz, Katrina R. , Sim, Leslie , Matthews, Abigail

Mayo Clinic

Practical Diabetes | April 10, 2017 | Volume: 34 | Issue: 3 | Pages: 95-98

10.1002/pdi.2091 Get It

AbstractAdolescents with type 1 diabetes mellitus (T1DM) are at increased risk for poor treatment adherence and glycaemic lability. Parental involvement in a youth's diabetes regimen is associated with better outcomes, yet supported treatments may be inaccessible due to limited community resources and financial constraints. Furthermore, existing interventions emphasise a collaborative effort between family members, which may not be effective with youth with particular vulnerabilities. Similarities between T1DM and anorexia nervosa prompted our use of modified family‐based therapy (FBT) with a 16‐year‐old male with poor glycaemic control. FBT‐guided strategies were brief and implemented by a family medicine physician at routine visits. Medical symptoms dramatically improved over a four‐month period, demonstrating that FBT tailored to T1DM warrants further investigation for youth with poor treatment adherence. Copyright © 2017 John Wiley & Sons.
Taxonomy for Education and Training in Clinical Neuropsychology : past, present, and future
Sperling, Scott A. , Cimino, Cynthia R., Stricker, Nikki H. , Heffelfinger, Amy , Gess, Jennifer L. , Osborn, Katie E. , Roper, Brad L. , Stricker, Nikki H , Sperling, Scott , Heffelfinger, Amy

Mayo Clinic

The Clinical Neuropsychologist | April 10, 2017 | Volume: 31 | Issue: 5 | Pages: 817-828

10.1080/13854046.2017.1314017 | PMID 28391739 Get It

S1 Molecular Mechanisms of Prostate Cancer Cell Survival following Androgen Ablative Therapy
Tindall, Donald J.

Mayo Clinic

The Japanese Journal of Urology | April 10, 2017 | Volume: 97 | Issue: 2 | Pages: 127

10.5980/jpnjurol.97.127_2 Get It

Electronic Medical Record‐Integrated Pharmacogenomics and Related Clinical Decision Support Concepts
Caraballo, PJ, Bielinski, Suzette J. , Sauver, JL St., Weinshilboum, RM, Sauver, Jennifer L. St. , Caraballo, Pedro J. , St Sauver, Jennifer L , Bielinski, Suzette

Mayo Clinic

Clinical Pharmacology & Therapeutics | April 8, 2017 | Volume: 102 | Issue: 2 | Pages: 254-264

10.1002/cpt.707 | PMID 28390138 Get It

Advances in pharmacogenomics (PGx) have the potential to transform healthcare by allowing precision medicine to become a reality. However, PGx knowledge is new, complex, and evolving, and relying on the cognition of clinicians alone is insufficient for clinical implementation. Integrating clinical decision support (CDS) tools in the electronic health record (EHR) is critical for translating PGx into clinical practice. Herein, we review current strategies to implement PGx using EHR‐CDS functionalities.
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
Deneau, Mark , El‐Matary, Wael , Valentino, Pamela L. , Abdou, Reham , Alqoaer, Khaled, Amin, Mansi , Amir, Achiya , Auth, Marcus , Broderick, Annemarie , Cotter, Jillian M. , Doan, Sylvia , El‐Youssef, Mounif, Ferrari, Federica , Furuya, Katryn N. , Gottrand, Madeleine, Gottrand, Frédèric , Gupta, Nitika , Kamath, Binita M. , Kolho, Kaija‐Leena , Konidari, Anastasia , Koot, Bart G.P. , Iorio, Raffaele , Mack, Cara L. , Miloh, Tamir , Mohan, Parvathi, O’Cathain, Niamh, Papadopoulou, Alexandra , Ricciuto, Amanda , Saubermann, Lawrence J., Sathya, Pushpa , Shteyer, Eyal , Smolka, Vratislav, Tanaka, Atushi, Varier, Raghu, Venkat, Veena, Vitola, Bernadette , Vos, Miriam B. , Woynarowski, Marek , Yap, Jason , Jensen, M. Kyle , Aumar, Madeleine , Deneau, Mark R , Bazerbachi, Fateh , El-Youssef, Mounif, Chan, Albert , Homan, Matjaž , Kim, Kyung Mo , Ledder, Oren , Martínez, Mercedes , Ricciuto, Amanda , Valentino, Pamela , Papadopoulou, Alexandra , Gottrand, Frederic

Mayo Clinic

Hepatology | April 8, 2017 | Volume: 66 | Issue: 2 | Pages: 518-527

10.1002/hep.29204 | PMID 28390159 Get It

There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the disease characteristics and long‐term outcomes of pediatric PSC. We retrospectively collected all pediatric PSC cases from 36 participating institutions and conducted a survival analysis from the date of PSC diagnosis to dates of diagnosis of portal hypertensive or biliary complications, cholangiocarcinoma, liver transplantation, or death. We analyzed patients grouped by disease phenotype and laboratory studies at diagnosis to identify objective predictors of long‐term outcome. We identified 781 patients, median age 12 years, with 4,277 person‐years of follow‐up; 33% with autoimmune hepatitis, 76% with inflammatory bowel disease, and 13% with small duct PSC. Portal hypertensive and biliary complications developed in 38% and 25%, respectively, after 10 years of disease. Once these complications developed, median survival with native liver was 2.8 and 3.5 years, respectively. Cholangiocarcinoma occurred in 1%. Overall event‐free survival was 70% at 5 years and 53% at 10 years. Patient groups with the most elevated total bilirubin, gamma‐glutamyltransferase, and aspartate aminotransferase‐to‐platelet ratio index at diagnosis had the worst outcomes. In multivariate analysis PSC–inflammatory bowel disease and small duct phenotypes were associated with favorable prognosis (hazard ratios 0.6, 95% confidence interval 0.5‐0.9, and 0.7, 95% confidence interval 0.5‐0.96, respectively). Age, gender, and autoimmune hepatitis overlap did not impact long‐term outcome. Conclusion: PSC has a chronic, progressive course in children, and nearly half of patients develop an adverse liver outcome after 10 years of disease; elevations in bilirubin, gamma‐glutamyltransferase, and aspartate aminotransferase‐to‐platelet ratio index at diagnosis can identify patients at highest risk; small duct PSC and PSC–inflammatory bowel disease are more favorable disease phenotypes. (Hepatology 2017;66:518–527).
The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide
Williams, Robert C. , Opelz, Gerhard, Weil, E. Jennifer , McGarvey, Chelsea J., Chakkera, Harini A. , Chakkera, Harini A

Mayo Clinic

Transplantation Direct | April 8, 2017 | Volume: 3 | Issue: 5 | Pages: e152

10.1097/txd.0000000000000664 | PMID 28573187 Get It

Background Allografts from living donors survive longer than those from deceased donors but the role of HLA mismatching in living kidney donation is still in question. We examined the effect of HLA compatibility on kidney allograft survival from living donors by studying all first adult kidney transplants performed in the United States over 25 years. Methods Using the United Network for Organ Sharing data, we identified first kidney transplants between October 1, 1987, and December 31, 2013. Recipients were classified by their number of HLA mismatches and stratified by donor origin. Cox multivariate regression analyses adjusting for recipient and donor transplant characteristics were performed to determine impact of HLA compatibility on kidney allograft survival for all living donors and for living related and living unrelated subsets. Results There were 66 596 first adult transplants from living donors with 348 960 years of follow-up. We found a linear relationship between HLA mismatch and allograft survival. In adjusted analyses, among all living donors, 1 mismatch conferred a 44% higher risk, whereas 6 mismatches conferred a twofold higher risk of allograft failure. When using 0-mismatched full siblings as a reference, living-donor kidneys reduce the hazard of failure by approximately 34% when compared with deceased donors. Twenty-five years of transplant experience, stratified by donor source, was summarized and presented as a guide for allocation. Conclusions These data reinforce the importance of optimizing HLA matching to further improve survival in first adult kidney allografts in the future, especially in living unrelated donations, when possible.
Sonographic Visualization of the Posterior Cutaneous Nerve of the Forearm: Technique and Validation Using Perineural Injections in a Cadaveric Model
Maida, Eugene , Chiavaras, Mary M., Jelsing, Elena J., O’Driscoll, Shawn W. , Pawlina, Wojciech, Smith, Jay , Fitzsimmons, James S

Mayo Clinic

Journal of Ultrasound in Medicine | April 8, 2017 | Volume: 36 | Issue: 8 | Pages: 1627-1637

10.7863/ultra.16.08027 | PMID 28390161 Get It

Objectives To determine the ability to sonographically identify the posterior cutaneous nerve of the forearm (PCNF) and its distal epicondylar branches using sonographically guided perineural injections in an unembalmed cadaveric model. Methods A single experienced operator used a 12–3‐MHz linear array transducer to identify the PCNF and its distal epicondylar region branches in 10 unembalmed cadaveric specimens (6 right and 4 left) obtained from 10 donors. Sonographically guided perineural PCNF injections were then completed with a 22‐gauge, 38‐mm stainless steel needle to deliver 0.25 mL of 50% diluted colored latex at 3 points along the PCNF. The latex location was then confirmed via dissection. Results The 10 donors included 4 male and 6 female cadavers aged 48 to 94 years (mean, 73 years) with body mass indices of 19 to 37 kg/m 2 (mean, 26 kg/m 2 ). The operator sonographically identified the PCNF and several distal branches traversing over or directly adjacent to the lateral epicondyle in all 10 specimens. Only 7 of 10 specimens showed a distinct PCNF bifurcation into anterior and posterior divisions, and all 7 were accurately identified and localized on sonography. There was no evidence of latex overflow to clinically relevant adjacent structures or injury to regional vessels or nerves. Conclusions High‐resolution sonography can identify the PCNF and its distal epicondylar branches. Sonographic evaluation of the PCNF should be included in the evaluation of patients presenting with refractory or atypical lateral elbow pain syndromes. Diagnostic and therapeutic sonographically guided procedures targeting the PCNF or its lateral epicondylar branches are feasible and warrant further investigation.